Telson Mining Corporation (CVE:TSN) (OTCMKTS:SOHFF) is one step closer to finalising construction of its flagship Tahuehueto project. The mining company announced Wednesday that it had received conditional approval for a line of credit worth US$12 million from an unnamed international investment bank.
WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) is raking in $10 million, the company announced Wednesday, thanks to a convertible debenture deal with Mackie Research Capital. The company sold 10,000 debenture units for $1,000 apiece on a bought-deal basis. Each individual unit contains a debenture with an 8.5% interest rate and 625 share purchase warrants, exercisable at a price of $1.80 per share.
Haywood Capital Markets reiterated a Buy rating and $3.50 target price on WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF), adding it views the cannabis producer as “undervalued when compared to its peer group." In a note to clients, Haywood analysts recommended buying shares at current prices, adding the firm reported "solid Q2/19 results with revenues well above expectations." Mackie Research also repeated a Buy rating on WeedMD in a note published today following the firm’s recent results, with a target price of $4.00.
Berkwood Resources Ltd. (CVE:BKR) has granted stock option agreements to its directors, officers and consultants for the right to purchase up to 930,000 common shares of the company, exercisable at the price of 5 cents per share for five years, subject to regulatory approval. The group said the option agreements to be issued will be granted in accordance with the company's stock option plan and, if necessary, will be subject to the TSX Venture Exchange four-month hold period.
Ozop Surgical Corp (OTCMKTS:OZSC), a spinal surgical device producer, announced Wednesday that it was tapping industry veteran Nick Ansari to head its sales team. Ansari steps in as executive vice president of sales and marketing after more than 20 years in the sector. Over the course of his career, Ansari has held senior roles at influential medical device companies including Stryker, Medtronic, Globus and Lanx/Biomet orthopedics.
PyroGenesis Canada Inc (CVE:PYR) (OCTMKTS:PYRNF) and partner HPQ Silicon Resources Inc (CVE:HPQ) have filed a new provisional patent application for their PUREVAP project which is designed to reduce the cost of making silicon metal. This is the second patent filing for PUREVAP since both companies teamed up in 2015. That first patent is still pending and allows the transformation and purification of quartz into metallurgical grade silicon metal at prices that show its clean energy potential.
Social Life Network, Inc (OTCMKTS:WDLF) subsidiary MjLink.com Inc announced Wednesday that Bruce Linton, the former co-founder of Canopy Growth Inc (TSE:WEED) (NYSE:CGC), will be the keynote speaker at its upcoming conference in Beverly Hills. Billed as “The next level in cannabis investment,” the MjMicro Conference is an invitational investor networking forum organised by MjLink.com. The conference, which will be held on October 16 at the Sofitel Hotel, unites C-level executives from presenting cannabis companies, in one-on-one meetings with private and institutional investors.
The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) noted that its institutional ownership has been boosted ahead of a planned listing on the tech-laden US Nasdaq market following Aurora Cannabis Inc's (NYSE:ACB) move to sell its remaining shareholding. In a statement on Wednesday, the company noted Aurora’s sale of the 28.83 million TGOD shares that it owned at a price of C$3 a share for gross proceeds of C$86.5 million.
Carube Copper Corp (CVE:CUV) (OTCMKTS:CARCF) has closed on its non-brokered private placement that raised $260,000. The explorer sold 5.2 million units at a price of $0.05 per unit. Each unit is comprised of one common share and one common share purchase warrant. Each warrant is exercisable into one common share at a price of $0.08 per share for a period of 36 months.
CytoDyn Inc (OTCMKTS:CYDY) revealed that it has filed an Investigational New Drug (IND) application and a Phase 2 clinical trial protocol with the US Food and Drug Administration for its flagship drug leronlimab to treat patients with non-alcoholic steatohepatitis (NASH). NASH is a chronic liver disease characterized by liver inflammation and damage caused by a buildup of fat in the liver. Patients with this disease are often told they have a "fatty liver." The 60-patient, multi-center, randomized, placebo-controlled Phase 2 study is designed to test the safety and potential in adult patients. In a statement, the Vancouver, Washington-based late-stage biotechnology company said leronlimab blocks CCR5, a cellular receptor, which has found to be important in HIV infection, tumor metastases, and NASH.
Royal Road Minerals Limited (CVE:RYR) (OTCMKTS:RRDMF) reported Wednesday the first highly encouraging drill results from the Luna Roja gold project in Nicaragua, which suggest further gold mineralization exists. Royal Road is the operator of the strategic alliance struck with Hemco Mineros Nicaragua in 2017, of which the project forms a part. The companies have completed an initial 17-hole, 2,472 meter, scout drilling program and results have been returned for the first 13.
TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) is teaming up with renowned financial advisory and consulting firm Deloitte Touche Tohmatsu Limited to bring increased transparency to the retail cannabis industry, the companies announced in a joint statement Wednesday. TruTrace’s StrainSecure system uses blockchain technology to trace cannabis from seed to sale, guaranteeing that customers and retailers alike know exactly what is changing hands.
PowerOre Inc (CVE:PORE) released new drill results from its flagship Opemiska copper project that uncovered new areas of mineralization in the Chibougamau district of Quebec. New results from the company’s current drill program include four mineralized intersections that exceeded 100 metres in length and above the firm’s cutoff grade, Power Ore told investors on Wednesday. The intersections include nearly 134 metres of 0.65% copper equivalent (CuEq) in one hole, with subsequent intersections revealing results of 102.1 metres of 0.57% CuEq, 100 metres of 0.36% CuEq and 114 metres of 0.48% CuEq.
LiteLink Technologies Inc (CSE:LLT) (OTCMKTS:LLNKF) said Wednesday its 1SHIFT Logistics platform has reached maturity as the company shifts its focus to sales and marketing across North America. The flagship software platform enables brokers, shippers and carriers to track shipments and settle payments in real-time without having to micro-manage individual drivers. In a statement to shareholders, the company said it has added an additional sales office in Montreal to increase its sales presence in Eastern Canada.
BevCanna Enterprises Inc. (CSE:BEV) (OTCMKTS:BVNNF) has signed a letter of intent with Clearwater CannGrow to produce sun-grown organic cannabis on 130 acres of its land. The plan, the company said in a statement Wednesday, is for CannGrow to plan and operate the cultivation on BevCanna’s plot of land near Osoyoos, British Columbia. The two companies expect to reach a definitive agreement on a three-year term within two weeks.
RYAH Medtech, Inc, a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry, announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to support the company’s public relations and investor relations programs. Gregory Wagner, the company’s chief executive officer said: “RYAH is entering a very exciting stage of its evolution with the recent commercial launch of our first-of-its-kind dose-measuring smart vaporizer which utilizes AI and data collection to provide optimal results and information for users.” He added: “KCSA has the experience and expertise to most effectively reach our target audiences and we are excited to partner with them as we move ahead.”
Exactus, Inc. (OTCQB:EXDI) announced that its corporate profile has been listed in MERGENT INDUSTRIAL and INTERNATIONAL Manuals and News Reports and is included in the bound August 2019 Monthly News Reports. Mergent Manuals and News Reports are a “recognized securities manual” in 39 states for purposes of Blue Sky Manual Exemption. The Exactus listing is intended to help facilitate trading of the company’s securities in secondary markets while targeting a vast audience of over one million investors and decision-makers.
Arcadia Biosciences Inc (NASDAQ:RKDA) announced Wednesday that CEO Matt Plavan will be presenting at the 21st Annual Global Investment Conference, held September 8-10 at the Lotte New York Palace Hotel. Plavan’s presentation is scheduled for 12:30 PM on Tuesday, September 10, and he also plans to meet one-on-one with investors. The presentation will serve as a business overview of the healthy food ingredient and nutritional oils company.
Acasti Pharma Inc. (NASDAQ:ACST) (CVE:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that it will be presenting at the 21st Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC, being held on September 8-10, 2019 at the Lotte New York Palace Hotel in New York City. Jan D’Alvise, Acasti’s chief executive officer, is scheduled to present on Monday, September 9, 2019 at 9:35 am Eastern Time.
Seelos Therapeutics Inc (NASDAQ:SEEL) told shareholders on Wednesday that it will participate in the Oppenheimer Fall Summit that focuses on specialty pharmaceutical and rare disease companies in New York City. The company will also host one-on-one meetings in New York City on Monday September 23rd and Tuesday September 24th. The biopharmaceutical firm develops and advances novel therapeutics for patients with central nervous system disorders.
Dyadic International Inc CEO Mark Emalfarb will be presenting at the Janney Montgomery Scott Healthcare Conference in New York on September 9 at 9:55 am ET. The Florida company applies its proprietary C1 gene expression platform to speed up the development of biologic vaccines, drugs at flexible commercial scales. Emalfarb will be available during the event for one-one-one meetings with investors.